SCHEMBL3585505

SCHEMBL3585505

CCCCC(CCC(=O)O)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.50
AKR1B1 P15121 1/20 0.48
GPR84 Q9NQS5 11/20 0.47
PPARG P37231 7/20 0.46
PPARD Q03181 7/20 0.46
PPARA Q07869 7/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
PTPN1 P18031 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46
ESR1 P03372 1/20 0.46
ALOX15 P16050 1/20 0.46
PDE4A P27815 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11295948 0.94 GPR84 (0.55) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL5978598 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL1768615 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL11293085 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL11290033 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL8528115 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL1768763 0.92 GPR84 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL26679462 0.92 AKR1B1 (0.54) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL10707793 0.91 GPR84 (0.54) CA2AKR1B1GPR84PPARGPPARD
SCHEMBL11287170 0.90 FFAR4 (0.58) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101111551-A Co-additive composition and method of applying same to nucleated polymer compounds MILLIKEN & CO (US) 2008-01-23 CN claimed
EP-0060224-A1 Corrosion protecting composition CIBA-GEIGY AG (CH) 1982-09-15 EP claimed
US-8455413-B2 Additive for oils and lubricant comprising the same KH NEOCHEM CO., LTD. (JP) 2013-06-04 US disclosed
CN-101029120-B Melt-processable polyurethanes and process for their preparation BAYER MATERIALSCIENCE AG 2011-06-15 CN disclosed
US-7842822-B2 Substituted benzopyrans as selective estrogen receptor-beta agonists ELI LILLY AND COMPANY (US) 2010-11-30 US disclosed
US-20100298183-A1 ADDITIVE FOR OILS AND LUBRICANT COMPRISING THE SAME KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2010-11-25 US disclosed
US-20090298925-A1 SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS DURST GREGORY LEE 2009-12-03 US disclosed
CN-101029120-A Melt-processable polyurethanes and process for their preparation BAYER MATERIALSCIENCE AG (DE) 2007-09-05 CN disclosed
US-4457924-A PENICILLINS, OXAPENICILLINS, BETA-LACTAMASE INHIBITORS PFIZER, INC. (US) 1984-07-03 US disclosed
EP-0060224-A1 Corrosion protecting composition CIBA-GEIGY AG (CH) 1982-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298183-A1 ADDITIVE FOR OILS AND LUBRICANT COMPRISING THE SAME NCOA2, NCOR2, NR1H2 CA2 3034/4885AKR1B1 590/4885GPR84 67/4885
US-20090298925-A1 SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS GPER1, ESR2, ESR1 CA2 2419/4885AKR1B1 271/4885GPR84 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.